Hide Board Information

Show Board Information

Biora Therapeutics, Inc. BIORQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/22/2023 6:06:38 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 6

Biora Therapeutics, Inc. (OTCMRKTS: BIORQ) Stock Message Board

1. BIORQ Company Profile

    

2. BIORQ Time & Sales

    

3. BIORQ Recent News

    

4. BIORQ Filings

    

5. BIORQ Financials

    

6. BIORQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$BIOR 31% v1,5M c4.85 f11,859M H5.10 ML2.26	znewcar1	05/22/2023 6:06:38 PM
5	$BIOR 155% v50,1M c5.40 f8,926M H5.63 ML1.95 off	znewcar1	01/10/2023 4:43:02 PM
4	BIOR 31% v30,9M c1.01 f184,2M H1.15 ML.6211	znewcar1	08/10/2022 5:36:14 PM
3	@1.28 still a bear	znewcar1	02/23/2022 1:30:51 PM
2	H2.11 @ 1.5 ML@1.11 downward slide (1)	znewcar1	02/18/2022 1:19:36 PM
1	PROG Stock Chart Video Analysis 02-08-2022	Chasing Stars	02/08/2022 8:14:59 PM

Recent Articles

• Biomea Fusion Launches Exciting New Public Offering Plans
• Primaris REIT's Major Acquisition Boosts Growth and Strategy
• Primaris REIT Expands Portfolio with $565 Million Mall Purchase
• Understanding the Current Investor Sentiment on Innodata Inc
• Understanding the Rising Short Interest in AeroVironment Inc
• Hongli Group Secures Compliance with Nasdaq Listing Standards
• Analyzing Short Interest Trends of The Western Union Co
• LXP Industrial Trust Announces Q3 Results Call for Investors
• Marpai, Inc. Secures $200,000 Funding from HillCour Investment
• The Overlooked Side of Real Estate Investing Most Individuals Miss
• American National Group Completes Redemption of Series B Shares
• Sprout Social Prepares to Reveal Q3 2025 Financial Insights
• Chart Industries to Provide Heat Transfer Solutions for LNG Project
• Constellation Brands Second Quarter Results: Insights for Investors
• Serina Therapeutics Secures Funding for Parkinson’s Disease Trial
• Black Titan Corporation Proposes Strategic Crypto Investments
• Apollo Funds Embrace Innovation with Eagle Creek Acquisition
• TCL Launches Major Discounts on TVs and Mobile Devices
• AI Infrastructure Acquisition Corp. Successfully Completes IPO
• Biomea Fusion Launches Innovative Offering to Boost Growth
• MapLight Therapeutics Initiates IPO to Advance CNS Treatments
• Kimberly-Clark Announces Upcoming Q3 2025 Financial Results
• Century Aluminum's Power Agreement Signals Growth and Jobs Expansion
• California Takes Action Against Flavored Tobacco to Safeguard Youth
• MidCap Financial Investment Corporation's Upcoming Earnings Call
• Equillium's New Leadership Takes Charge in Biotech Innovations
• Veeco Instruments Unveils Advanced Lumina+ MOCVD System and Orders
• Biomea Fusion Reports Milestone 52-Week Findings in Diabetes
• Crinetics Pharmaceuticals: Anticipating Q3 Results and Future Plans
• Innovative Food Holdings Transitions Leadership for Growth
• Preferred Bank to Host Q3 Earnings Call: Key Details Inside
• A Look at Your Investment in Orla Mining Over 5 Years
• Encore Capital Group: A Preview of Third Quarter Results
• Dorman Products Prepares to Share Third Quarter Financials
• MidCap Financial Investment Corporation Announces Earnings Call Details
• Tile Shop's Strategic Move: Delisting for Long-Term Growth
• Equillium's Strategic Changes and Future Aspirations Unveiled
• NN, Inc. Enhances Its Aerospace and Defense Operations
• Veeco's Lumina+ System: Advancing Compound Semiconductor Production
• Biomea Fusion's Icovamenib Shines in Phase II Diabetes Study
• Senseonics Reports Significant Q3 Growth and Stock Split Plans
• Encore Capital Group Set to Release Q3 2025 Financial Results
• Immix Biopharma to Showcase Innovative NXC-201 Research Soon
• Tile Shop Plans to Delist from Nasdaq to Boost Stockholder Value
• High Court of Justice Approves Verona Pharma's Acquisition by MSD
• Crinetics Pharmaceuticals Prepares for Q3 2025 Earnings Call
• Armada Hoffler Prepares for Third Quarter Earnings Report
• High Court Sanctions Verona Pharma Acquisition by MSD
• Sprout Social to Release Q3 2025 Financial Results Soon
• Armada Hoffler Sets Date for Q3 Earnings Report Soon